Researchers say bioavailability ‘shortcut’ could become industry standard
Researchers developing a method to determine drug bioavailability say the approach could become a ‘shortcut’ for scientists in drug discovery and development.
Researchers developing a method to determine drug bioavailability say the approach could become a ‘shortcut’ for scientists in drug discovery and development.
The US FDA has revealed its work plan for implementing aspects of the 21st Century Cures Act, including an investment in in silico tools for use in clinical trials.
Catalent Pharma Solutions has expanded its OptiForm Solution Suite platform from candidate selection through Phase I.
Mendel.ai has raised $2m in seed funding to advance its artificial intelligence engine that connects doctors and patients with clinical trials.
Idifarma has bolstered its capsule filling capabilities at its manufacturing plant in Pamplona, Spain.
The US FDA has promised to review Spark Therapeutics’ candidate vision loss gene therapy Luxturna by next January.
Pfizer Inc. has awarded Catalent Pharma Solutions the long-term manufacturing contract for a smaller version of its over-the-counter (OTC) painkiller Advil (ibuprofen).